Shares of Proteome Sciences plc (LON:PRM – Get Free Report) shot up 9% during trading on Monday . The company traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). 967,070 shares were traded during trading, an increase of 496% from the average session volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Trading Up 3.5 %
The company has a fifty day moving average of GBX 2.72 and a 200-day moving average of GBX 3.15. The company has a market capitalization of £9.65 million, a price-to-earnings ratio of -327.00 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 2 Drone Stocks Surging from Increased Media Attention
- What is the S&P/TSX Index?
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
